A Note On 23andMe’s New Collaboration with GSK

July 25, 2018
23andMe announces the launch of a collaboration with GlaxoSmithKline (GSK) to accelerate our ability to make meaningful discoveries in therapeutics to treat disease.
Read More

Drug Development’s Long And Winding Road

January 21, 2015
Before a medicine reaches pharmacy shelves, it goes through extensive and rigorous evaluation to prove it is safe and effective.We want to shed some light on a few of the...
Read More

23andMe’s Research At ASHG 2014

October 21, 2014
Geneticists from all over the world have converged in San Diego this week as part of the American Society of Human Genetics annual meeting. A team of scientists from 23andMe...
Read More

SNPwatch: More Evidence That Genetic Variations are Important for Hepatitis C Infection and Treatment

September 18, 2009
Unlike the flu virus, which the body is generally able to fight off completely, infection with hepatitis C is often chronic.   That means for most of the three to...
Read More

Researchers Take A Step Toward Developing New Drugs For Crohn’s Disease

July 16, 2009
The exact causes of Crohn’s disease remain a mystery, but scientists do know that genetic factors play an important part. More than 30 variations have been associated with increased risk...
Read More

Researchers Warn That Drug Development Based On Obesity Genetics Could Deliver More Than Is Bargained For

June 26, 2009
Not surprisingly, there has been intense interest in the genetics of obesity in recent years.   Obesity is a major health problem, resulting in tens of thousands of premature deaths...
Read More